Asterion Cannabis Inc.
Asterion Cannabis Inc.
- Land: .
Nachricht vom 23.05.2019 | 21:19
Asterion to Hold 2019 Annual General Meeting and Corporate Presentations
DGAP-News: Asterion Cannabis Inc. / Key word(s): Miscellaneous
Vancouver, British Columbia--(Newsfile Corp. - May 23, 2019) - Asterion Cannabis Inc. (P.ASTR) ("Asterion" or the "Company") announces that the Company's 2019 Annual General Meeting of Shareholders will be held at the Fairmont Vancouver Hotel in the Saturna Room, 900 West Georgia Street, Vancouver, BC, Canada on Thursday, June 20, 2019 at 12:00 p.m.
Asterion is also pleased to announce that it will be hosting two corporate events involving presentations from Asterion's senior management, details of which are set out below. Presenters at the events are expected to include Mr. Stephen Van Deventer, Chairman and CEO, Mr. Paget Hargreaves, President and Director, Mr. Hamish Sutherland, Chief Operating Officer and Mr. Stewart McGlashan, Director of Project Development.
Due to limited space, please pre-register for the events to secure your spot.
Toronto Corporate Presentation Event Details
MC: Stephen Van Deventer
Toronto - Confirm your attendance, register by clicking here: Toronto Eventbrite Link
Vancouver Corporate Presentation Event Details
Vancouver - Confirm your attendance, register by clicking here: Vancouver Eventbrite Link
Asterion is a Canadian medicinal cannabis company with operations in Australia, specializing in medical cannabis and is focused on becoming an industry leader in next-generation cannabis products. The Company is focused on the future of precision agriculture and aims to produce the highest quality of genetically uniform cannabis strains, at an affordable price.
The Company is led by a team of highly experienced executives with over 120 years of combined experience in medical cannabis, renewable energy, capital markets, and other highly relevant sectors across North America, Oceania, Europe, Africa and Asia.
On Behalf of the Board of Directors
"Stephen Van Deventer"
For further information, please contact:
This news release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995. Other than statements of historical fact, all statements included in this news release, including, without limitation, statements regarding the Company's anticipated business plans and prospects of success in executing its plans, are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Various risks and uncertainties could cause actual results to differ materially from Asterion's expectations. Other factors such as general economic, market or business conditions, future prices of cannabis, changes in the financial markets and in the demand and market price for cannabis, or changes in laws, regulations and policies affecting the biotechnology or cannabis industry, and delays in obtaining governmental and regulatory approvals, may also adversely affect the future results or performance of the Company. Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/45012
Click on, or paste the following link into your web browser,to view the associated documents http://www.newsfilecorp.com/release/45012
|Company:||Asterion Cannabis Inc.|
|EQS News ID:||815447|
|End of News||DGAP News Service|
Fonds Research 2019: Dt. Mittelstandsanleihen FONDS bietet attraktive Anlagemöglichkeit
Auch 2019 hat die GBC AG unter der Vielzahl an Publikumsfonds neun „Fonds Champions“ herausgefiltert. Darunter den Deutsche Mittelstandsanleihen FONDS (ISIN: LU0974225590), der eine qualitätsorientierte Strategie verfolgt und eine vielversprechende Anlagemöglichkeit in den deutschen Mittelstand bietet. Insbesondere vor dem Hintergrund des aktuellen Niedrigzinsniveaus sehen wir den Fonds als gute Chance, um attraktive Renditen zu erwirtschaften und dies verbunden mit einer traditionell niedrigen Fonds-Volatilität. Wir vergeben 5 von 5 GBC-Falken ein.
Der AKTIONÄR News
18. September 20:00 Joker Draghi: Raubzug am Sparer – Geldsegen für Aktionäre
18. September 15:17 Allianz: Wird der Gegenwind von der Fed schärfer?
18. September 14:30 Wirecard-CEO Braun kontert kritischen Bericht mit Aussicht auf ...
18. September 14:23 Ballard-Power-Rivale PowerCell: Der nächste Auftrag!
18. September 14:20 Nestlé: Grüne Welle
News im Fokus
E.ON SE: E.ON vollzieht Erwerb der innogy-Anteile von RWE
18. September 2019, 22:30
Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index
18. September 2019